Risk factors for recurrent rejection in pediatric heart transplantation: A multicenter experience

被引:88
作者
Chin, C
Naftel, DC
Singh, TP
Blume, ED
Luikart, H
Bernstein, D
Gamberg, P
Kirklin, JK
Morrow, WR
机构
[1] Stanford Univ, Div Pediat Cardiol, Palo Alto, CA 94304 USA
[2] Univ Alabama, Div Cardiothorac Surg, Birmingham, AL USA
[3] Boston Childrens Hosp, Boston, MA USA
[4] Childrens Hosp Michigan, Detroit, MI 48201 USA
[5] Univ Arkansas, Arkansas Childrens Hosp, Little Rock, AR 72204 USA
关键词
D O I
10.1016/S1053-2498(03)00059-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiac allograft rejection remains as a primary cause of death in the first 3 years after pediatric heart transplantation. Multiple episode of acute rejection in adult heart transplant recipients may accelerate the development of graft vasculopathy. We sought to quantify the time-related probability of recurrent rejection and identify risk factors for the development of recurrent rejection. Methods: We analyzed data from 847 pediatric recipients who underwent transplantation between January 1, 1993 and December 31, 1998 at, 22 centers in the Pediatric Heart Transplant Study (PHTS). Recurrent rejection and risk factors were evaluated using univariate and multivariate analyses. Results: Five hundred fifty two patients had 1,072 rejection events and were the subject of the analyses. The highest risk of recurrent rejection occurs within 1 month after resolution of a previous rejection episode. Risk factors for recurrent rejection include the number of previous rejection events, the elapsed time since a previous rejection episode, and subjects of either Hispanic or African-American descent. Rejection associated with hemodynamic compromise and late rejection is associated with higher mortality. Conclusions: Recurrent rejection is a risk factor for mortality, especially in the presence of hemodynamic compromise. This association appears independent of the time post-transplantation. Use of surveillance biopsies appears warranted throughout the life of the transplant individual. Retransplantation should be considered among these subjects with recurrent rejection.
引用
收藏
页码:178 / 185
页数:8
相关论文
共 12 条
[1]  
BOUCEK MM, 1994, J HEART LUNG TRANSPL, V13, P66
[2]   Induction immunotherapy in pediatric heart transplant recipients: A multicenter study [J].
Boucek, RJ ;
Naftel, D ;
Boucek, MM ;
Chinnock, R ;
Morrow, RW ;
Pahl, E ;
DiSano, S .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (05) :460-469
[3]   Safety and utility of the routine surveillance biopsy in pediatric patients 2 years after heart transplantation [J].
Chin, C ;
Akhtar, MJ ;
Rosenthal, DN ;
Bernstein, D .
JOURNAL OF PEDIATRICS, 2000, 136 (02) :238-242
[4]  
Frazier E. A., 1999, Journal of Heart and Lung Transplantation, V18, P69
[5]  
GRICE WN, 1987, CIRCULATION, V76, P150
[6]  
JARCHO J, 1994, J HEART LUNG TRANSPL, V13, P583
[7]  
KOBASHIGAWA JA, 1993, J HEART LUNG TRANSPL, V12, P355
[8]  
KUBO SH, 1995, J HEART LUNG TRANSPL, V14, P409
[9]  
Mills RM, 1997, J HEART LUNG TRANSPL, V16, P813
[10]  
Shaddy RE, 1996, CIRCULATION, V94, P69